Netherlands: Royal DSM reports 231% leap in profit

The company’s nutrition operations contributed €7.03 billion of the annual sales

Dutch nutrition, health, and materials giant Royal DSM has reported 2021 net profit of €1.67 billion, up 231% from €499 million reported for 2020.

The sales figure for 2021 was €9.2 billion, up 14% from €8.11 billion reported for 2020. The company’s nutrition operations contributed €7.03 billion of the annual sales.

Royal DSM’s joint chief executives Geraldine Matchett and Dimitri de Vreeze said in a statement: “2021 was a pivotal year for DSM and our people in which we accelerated our journey towards becoming a fully focused health, nutrition and bioscience company. In line with our purpose-led strategy, we took further significant climate action and set a more aggressive path towards net zero. We also launched ambitious new food system commitments to target and measure where we can best make a meaningful impact on the health of people and the planet through our core activities,

“Both nutrition and materials realised strong results as we continue to successfully navigate dynamic market conditions including global supply chain and logistics disruptions. We started to counter inflationary pressures in the second half of the year with appropriate pricing actions to offset cost increases, of which the first positive effects can be seen in the fourth quarter, with the remainder being effective as of 2022.

“We are well positioned going forward, with an exciting innovation portfolio of sustainability-focused solutions with considerable growth potential such as our methane-inhibiting livestock feed additive Bovaer. We have a positive outlook for 2022 in line with our mid-term strategic targets for our health, nutrition and bioscience activities.